🚨BREAKING: preliminary data from an ongoing clinical study of #remdesivir showed that in 113 patients with severe #COVID19:— Dr. Dena Grayson (@DrDenaGrayson) April 17, 2020
▶️Fever/symptoms rapidly improved
▶️Most discharged within 6 days
▶️2 died (1.8%), much less than expected for severe #COVID19https://t.co/XsgC7ryiri